ECSP13012668A - Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso - Google Patents
Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su usoInfo
- Publication number
- ECSP13012668A ECSP13012668A ECSP13012668A ECSP13012668A EC SP13012668 A ECSP13012668 A EC SP13012668A EC SP13012668 A ECSP13012668 A EC SP13012668A EC SP13012668 A ECSP13012668 A EC SP13012668A
- Authority
- EC
- Ecuador
- Prior art keywords
- bencilcicloalquilcarboxílicos
- acids substituted
- treatment
- prevention
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/55—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente solicitud se refiere a nuevos derivados de ácido 1-bencilcicloalquilcarboxílico sustituidos, procedimientos para su preparación, su uso para el tratamiento y/o la prevención de enfermedades y su uso para la preparación de medicamentos para el tratamiento y/o la prevención de enfermedades, especialmente para el tratamiento y/o la prevención enfermedades cardiovasculares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102010062544A DE102010062544A1 (de) | 2010-12-07 | 2010-12-07 | Substituierte 1-Benzylcycloalkylcarbonsäuren und ihre Verwendung |
DE102011006974A DE102011006974A1 (de) | 2011-04-07 | 2011-04-07 | Substituierte 1-Benzylcycloalkylcarbonsäuren und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP13012668A true ECSP13012668A (es) | 2013-08-30 |
Family
ID=45463539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP13012668 ECSP13012668A (es) | 2010-12-07 | 2013-06-07 | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso |
Country Status (26)
Country | Link |
---|---|
US (1) | US9018258B2 (es) |
EP (1) | EP2649045B1 (es) |
JP (1) | JP5989660B2 (es) |
KR (1) | KR20130136504A (es) |
CN (1) | CN103492361B (es) |
AP (1) | AP2013006953A0 (es) |
AR (1) | AR084220A1 (es) |
AU (1) | AU2011340721A1 (es) |
BR (1) | BR112013013663A2 (es) |
CA (1) | CA2819880C (es) |
CL (1) | CL2013001600A1 (es) |
CO (1) | CO6771409A2 (es) |
CR (1) | CR20130259A (es) |
DO (1) | DOP2013000125A (es) |
EA (1) | EA201300669A1 (es) |
EC (1) | ECSP13012668A (es) |
ES (1) | ES2544532T3 (es) |
HK (1) | HK1192879A1 (es) |
IL (1) | IL226422A0 (es) |
MA (1) | MA34721B1 (es) |
MX (1) | MX2013006053A (es) |
SG (1) | SG190296A1 (es) |
TW (1) | TW201249782A (es) |
UY (1) | UY33776A (es) |
WO (1) | WO2012076466A2 (es) |
ZA (1) | ZA201305076B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009012314A1 (de) * | 2009-03-09 | 2010-09-16 | Bayer Schering Pharma Aktiengesellschaft | Oxo-heterocyclisch substituierte Alkylcarbonsäuren und ihre Verwendung |
DE102009046115A1 (de) | 2009-10-28 | 2011-09-08 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 3-Phenylpropansäuren und ihre Verwendung |
DE102011007272A1 (de) * | 2011-04-13 | 2012-10-18 | Bayer Pharma Aktiengesellschaft | Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung |
DE102012208530A1 (de) | 2012-05-22 | 2013-11-28 | Bayer Pharma AG | Substituierte Piperidinoacetamide und ihre Verwendung |
EP2900639B1 (en) | 2012-09-27 | 2017-08-16 | Portola Pharmaceuticals, Inc. | Bicyclic dihydropyridone kinase inhibitors |
CN104058990B (zh) * | 2013-03-21 | 2017-03-15 | 博瑞生物医药(苏州)股份有限公司 | 一种阿利克仑或其盐的分离分析方法 |
TW201625586A (zh) | 2014-07-02 | 2016-07-16 | 諾華公司 | 環己烯-1-基-吡啶-2-基-1h-吡唑-4-羧酸衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
TW201625601A (zh) | 2014-07-02 | 2016-07-16 | 諾華公司 | 噻吩-2-基-吡啶-2-基-1h-吡唑-4-羧酸衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
TW201625584A (zh) | 2014-07-02 | 2016-07-16 | 諾華公司 | 茚滿及吲哚啉衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
KR20170066310A (ko) * | 2014-09-29 | 2017-06-14 | 닛산 가가쿠 고교 가부시키 가이샤 | 제미널 디플루오로 화합물의 제조 방법 |
EA035788B1 (ru) | 2014-12-18 | 2020-08-11 | Байер Фарма Акциенгезельшафт | Замещенный пиридил-циклоалкил-карбоновые кислоты, содержащие их композиции и их медицинское применение |
CN107580495A (zh) | 2015-05-06 | 2018-01-12 | 拜耳制药股份公司 | 单独和与PDE5抑制剂组合的sGC刺激剂、sGC活化剂用于治疗伴随系统性硬化症(SSc)的指溃疡(DU)的用途 |
DK3325013T4 (da) | 2015-07-23 | 2023-10-16 | Bayer Pharma AG | Stimulatorer og/eller aktivatorer af den opløselige guanylatcyklase (sgc) i kombination med en inhibitor af den neutrale endopeptidase (nep inhibitor) og en angiotensin aii-antagonist og deres anvendelse |
CN109890379A (zh) | 2016-10-11 | 2019-06-14 | 拜耳制药股份公司 | 包含sGC活化剂和盐皮质激素受体拮抗剂的组合产品 |
WO2019081456A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Aktiengesellschaft | USE OF SGC ACTIVATORS AND STIMULATORS COMPRISING A BETA2 SUBUNIT |
SG11202004577VA (en) * | 2017-12-01 | 2020-06-29 | Bayer Pharma AG | Method for producing (3s)-3-(4-chlor-3-{[(2s,3r)-2-(4-chlorphenyl)-4,4,4-trifluor-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient |
EP3498298A1 (en) | 2017-12-15 | 2019-06-19 | Bayer AG | The use of sgc stimulators and sgc activators alone or in combination with pde5 inhibitors for the treatment of bone disorders including osteogenesis imperfecta (oi) |
US20210032253A1 (en) | 2018-02-06 | 2021-02-04 | Jiangsu Hengrui Medicine Co., Ltd. | Pyrazolo[1,5-a][1,3,5]triazine-2-amine derivative, preparation method therefor and medical use thereof |
CA3098475A1 (en) | 2018-04-30 | 2019-11-07 | Bayer Aktiengesellschaft | The use of sgc activators and sgc stimulators for the treatment of cognitive impairment |
WO2019219672A1 (en) | 2018-05-15 | 2019-11-21 | Bayer Aktiengesellschaft | 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization |
US11508483B2 (en) | 2018-05-30 | 2022-11-22 | Adverio Pharma Gmbh | Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control group |
US10905667B2 (en) | 2018-07-24 | 2021-02-02 | Bayer Pharma Aktiengesellschaft | Orally administrable modified-release pharmaceutical dosage form |
WO2020148379A1 (en) | 2019-01-17 | 2020-07-23 | Bayer Aktiengesellschaft | Methods to determine whether a subject is suitable of being treated with an agonist of soluble guanylyl cyclase (sgc) |
WO2020164008A1 (en) | 2019-02-13 | 2020-08-20 | Bayer Aktiengesellschaft | Process for the preparation of porous microparticles |
TW202112359A (zh) | 2019-06-07 | 2021-04-01 | 德商拜耳廠股份有限公司 | sGC活化劑於治療眼科疾病之用途 |
EP4136066A1 (en) * | 2020-04-17 | 2023-02-22 | DSM IP Assets B.V. | A process for preparation of substituted enamine compounds |
CA3204596A1 (en) | 2020-12-10 | 2022-06-16 | Bayer Aktiengesellschaft | The use of sgc activators for the treatment of ophthalmologic diseases |
TW202317510A (zh) * | 2021-07-15 | 2023-05-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 3-苯基丙酸類化合物、其製備方法及其在醫藥上的應用 |
CN114478326B (zh) * | 2022-01-21 | 2023-10-03 | 安徽宁亿泰科技有限公司 | 一种苯嘧磺草胺关键中间体的合成方法 |
TW202342420A (zh) * | 2022-02-18 | 2023-11-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 羧酸類化合物、其製備方法及其在醫藥上的應用 |
TW202412753A (zh) | 2022-06-09 | 2024-04-01 | 德商拜耳廠股份有限公司 | 用於治療女性心臟衰竭合併保留射出分率的可溶性鳥苷酸環化酶活化劑 |
CN115838338A (zh) * | 2022-11-29 | 2023-03-24 | 浙江工业大学 | 一种制备酰胺的方法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041453A (en) | 1990-05-30 | 1991-08-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 |
DE4301900A1 (de) | 1993-01-25 | 1994-07-28 | Bayer Ag | 2-Oxochinolin-1-yl-methylphenylessigsäurederivate |
US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
DE4443892A1 (de) | 1994-12-09 | 1996-06-13 | Bayer Ag | 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate |
US5650386A (en) | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
DE19535504A1 (de) | 1995-09-25 | 1997-03-27 | Bayer Ag | Substituierte Xanthine |
DE19546918A1 (de) | 1995-12-15 | 1997-06-19 | Bayer Ag | Bicyclische Heterocyclen |
EP0802192A1 (de) | 1996-04-17 | 1997-10-22 | Bayer Ag | Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung |
DE19821483A1 (de) | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
PT1177187E (pt) | 1999-04-28 | 2007-09-03 | Sanofi Aventis Deutschland | Derivados ácidos de di-arilo como ligados do receptor ppar. |
HUP0200997A3 (en) | 1999-04-28 | 2003-03-28 | Sanofi Aventis Deutschland | Tri-aryl acid derivatives as ppar receptor ligands and pharmaceutical compositions containing them |
CA2385972A1 (en) | 1999-10-01 | 2001-04-12 | Haruhisa Ogita | Novel diarylamide derivatives and use thereof as medicines |
TWI262185B (en) | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
ATE407919T1 (de) | 2000-05-29 | 2008-09-15 | Kyorin Seiyaku Kk | Substituierte phenylpropionsäure-derivate |
EP1312601A4 (en) | 2000-08-22 | 2005-09-21 | Ono Pharmaceutical Co | CARBOXYLENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
EP1348698A4 (en) | 2000-12-05 | 2005-01-19 | Kyorin Seiyaku Kk | SUBSTITUTED CARBOXYLENE DERIVATIVES |
CA2433573A1 (en) | 2000-12-28 | 2002-07-11 | Takeda Chemical Industries, Ltd. | Alkanoic acid derivatives, process for their production and use thereof |
US7241785B2 (en) | 2001-03-23 | 2007-07-10 | Takeda Pharmaceutical Company Limited | Five-membered heterocyclic alkanoic acid derivative |
EP1375472A4 (en) | 2001-03-30 | 2008-12-10 | Eisai R&D Man Co Ltd | BENZENE COMPOUND AND SALT THEREOF |
IL160253A0 (en) | 2001-08-09 | 2004-07-25 | Ono Pharmaceutical Co | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
JPWO2003016265A1 (ja) | 2001-08-17 | 2004-12-02 | エーザイ株式会社 | 環状化合物およびpparアゴニスト |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
US7368578B2 (en) | 2002-09-10 | 2008-05-06 | Takeda Pharmaceutical Company Limited | Five-membered heterocyclic compounds |
US20050234066A1 (en) | 2004-04-15 | 2005-10-20 | Agouron Pharmaceuticals, Inc. | Alpha substituted carboxylic acids |
US20050187266A1 (en) | 2003-04-15 | 2005-08-25 | Pfizer Inc | Alpha substituted carboxylic acids |
CN1812978A (zh) | 2003-04-30 | 2006-08-02 | 药物研发有限责任公司 | 作为蛋白酪氨酸磷酸酶-1b抑制剂的苯基取代羧酸 |
EA011010B1 (ru) | 2004-02-27 | 2008-12-30 | Эмджен, Инк. | Соединения, модулирующие рецептор gpr40, фармацевтическая композиция, способ лечения заболеваний, чувствительных к модулированию рецептора gpr40 (варианты), способ модулирования функции gpr40 (варианты) и способ модулирования циркулирующей концентрации инсулина |
JP2008518926A (ja) | 2004-10-28 | 2008-06-05 | ジ インスティチューツ フォー ファーマシューティカル ディスカバリー、エルエルシー | 置換フェニルアルカン酸 |
CA2587566A1 (en) | 2004-11-18 | 2006-05-26 | The Institutes For Pharmaceutical Discovery, Llc | Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors |
US20110092554A1 (en) | 2007-11-19 | 2011-04-21 | Richard Chesworth | 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders |
DE102008018675A1 (de) * | 2008-04-14 | 2009-10-15 | Bayer Schering Pharma Aktiengesellschaft | Oxo-heterocyclisch substituierte Carbonsäure-Derivate und ihre Verwendung |
DE102009012314A1 (de) | 2009-03-09 | 2010-09-16 | Bayer Schering Pharma Aktiengesellschaft | Oxo-heterocyclisch substituierte Alkylcarbonsäuren und ihre Verwendung |
DE102009046115A1 (de) | 2009-10-28 | 2011-09-08 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 3-Phenylpropansäuren und ihre Verwendung |
DE102011007272A1 (de) | 2011-04-13 | 2012-10-18 | Bayer Pharma Aktiengesellschaft | Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung |
-
2011
- 2011-12-05 CN CN201180066977.8A patent/CN103492361B/zh not_active Expired - Fee Related
- 2011-12-05 EA EA201300669A patent/EA201300669A1/ru unknown
- 2011-12-05 WO PCT/EP2011/071747 patent/WO2012076466A2/de active Application Filing
- 2011-12-05 SG SG2013037502A patent/SG190296A1/en unknown
- 2011-12-05 EP EP11805433.7A patent/EP2649045B1/de not_active Not-in-force
- 2011-12-05 BR BR112013013663A patent/BR112013013663A2/pt not_active IP Right Cessation
- 2011-12-05 CA CA2819880A patent/CA2819880C/en not_active Expired - Fee Related
- 2011-12-05 KR KR1020137017749A patent/KR20130136504A/ko not_active Application Discontinuation
- 2011-12-05 ES ES11805433.7T patent/ES2544532T3/es active Active
- 2011-12-05 JP JP2013542493A patent/JP5989660B2/ja not_active Expired - Fee Related
- 2011-12-05 AU AU2011340721A patent/AU2011340721A1/en not_active Abandoned
- 2011-12-05 AP AP2013006953A patent/AP2013006953A0/xx unknown
- 2011-12-05 MX MX2013006053A patent/MX2013006053A/es not_active Application Discontinuation
- 2011-12-06 TW TW100144758A patent/TW201249782A/zh unknown
- 2011-12-06 US US13/312,320 patent/US9018258B2/en active Active
- 2011-12-07 AR ARP110104601 patent/AR084220A1/es not_active Application Discontinuation
- 2011-12-07 UY UY33776A patent/UY33776A/es not_active Application Discontinuation
-
2013
- 2013-05-19 IL IL226422A patent/IL226422A0/en unknown
- 2013-05-30 CO CO13132647A patent/CO6771409A2/es not_active Application Discontinuation
- 2013-06-04 DO DO2013000125A patent/DOP2013000125A/es unknown
- 2013-06-04 CR CR20130259A patent/CR20130259A/es unknown
- 2013-06-05 CL CL2013001600A patent/CL2013001600A1/es unknown
- 2013-06-05 MA MA35974A patent/MA34721B1/fr unknown
- 2013-06-07 EC ECSP13012668 patent/ECSP13012668A/es unknown
- 2013-07-05 ZA ZA2013/05076A patent/ZA201305076B/en unknown
-
2014
- 2014-06-27 HK HK14106471.9A patent/HK1192879A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CL2013001600A1 (es) | 2013-10-25 |
BR112013013663A2 (pt) | 2016-09-06 |
US9018258B2 (en) | 2015-04-28 |
AU2011340721A1 (en) | 2013-06-20 |
CA2819880A1 (en) | 2012-06-14 |
MA34721B1 (fr) | 2013-12-03 |
JP2014510017A (ja) | 2014-04-24 |
JP5989660B2 (ja) | 2016-09-07 |
WO2012076466A2 (de) | 2012-06-14 |
UY33776A (es) | 2012-06-29 |
SG190296A1 (en) | 2013-06-28 |
TW201249782A (en) | 2012-12-16 |
CR20130259A (es) | 2013-06-28 |
CN103492361B (zh) | 2015-07-15 |
US20120172448A1 (en) | 2012-07-05 |
HK1192879A1 (zh) | 2014-09-05 |
EP2649045B1 (de) | 2015-05-27 |
CA2819880C (en) | 2019-01-22 |
ZA201305076B (en) | 2014-12-23 |
EA201300669A1 (ru) | 2013-11-29 |
AP2013006953A0 (en) | 2013-06-30 |
EP2649045A2 (de) | 2013-10-16 |
CO6771409A2 (es) | 2013-10-15 |
ES2544532T3 (es) | 2015-09-01 |
MX2013006053A (es) | 2013-06-18 |
IL226422A0 (en) | 2013-07-31 |
CN103492361A (zh) | 2014-01-01 |
AR084220A1 (es) | 2013-05-02 |
KR20130136504A (ko) | 2013-12-12 |
WO2012076466A3 (de) | 2012-08-30 |
DOP2013000125A (es) | 2013-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
CO7240369A2 (es) | Ácido 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso | |
UY32970A (es) | Acidos 3-fenilpropionicos sustituidos y su uso | |
ECSP12012125A (es) | Ariltriazolonas ligadas a bisarilo y su uso | |
GT201300243A (es) | Derivados de ácido 3-fenilpropiónico ramificados y su uso | |
UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
CU24037B1 (es) | Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido | |
ECSP12012310A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
DOP2011000285A (es) | 2-acetamido-5-aril-1, 2, 4-triazolonas sustituidas y su uso | |
CU20090148A7 (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
AR058098A1 (es) | Derivados de acidos dicarboxilicos y su uso | |
UY31310A1 (es) | Ácidos 6-fenilnicotínicos sustituidos y su uso | |
CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
GT200600109A (es) | Derivados de acido pirimidincarboxilico y su uso | |
UY30582A1 (es) | Derivados de acido 2-fenoxinicotinico y su uso | |
UY31903A (es) | 7-sulfanilmetil-,7-silfinilmetil-y7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
CU20130078A7 (es) | Ácidos 1-bencicloalquilcarboxílicos sustituidos y su uso | |
CU20100260A7 (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
CR20120445A (es) | Ariltriazolonas ligadas a bisarilo y su uso | |
CU23704B7 (es) | Nuevos derivados de furopirimidina acíclicos sustituidos y su uso | |
CU20100183A7 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa |